BusinessCURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to UplistingBy Nasdaq OMXFeb 21, 2018, 11:00 AM UTC
BusinessEnhanced MuScreen™ Platform Revolutionizes Preclinical Development of ImmunotherapeuticsBy Nasdaq OMXFeb 9, 2018, 1:00 PM UTC
BusinessMedipure Pharmaceuticals Inc. Announces Appointment of Dr. Kaiji Hu as Research Scientist - Cell and Molecular BiologyBy Nasdaq OMXFeb 6, 2018, 2:00 PM UTC
BusinessData on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018By Nasdaq OMXJan 23, 2018, 1:40 PM UTC
BusinessInnovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live WebinarBy Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinesseClinical Data Volume and Diversity Pose Increasing Challenges and Delays, According to the Tufts Center for the Study of Drug DevelopmentBy Nasdaq OMXJan 9, 2018, 2:01 PM UTC
BusinessCrown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination StudiesBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
